Location History:
- Kawashimamachi, JP (1986 - 1997)
- Hajima-gun, JP (2000)
- Gifu, JP (2001)
Company Filing History:
Years Active: 1986-2001
Title: Innovations of Hiroshi Yamamoto
Introduction
Hiroshi Yamamoto is a notable inventor based in Kawashimamachi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address immuno-deficiency diseases.
Latest Patents
Hiroshi Yamamoto holds five patents, with his latest innovations focusing on β,γ-dihydropolyprenyl alcohol derivatives. These compounds are described as new and useful prophylactic therapeutic agents for both human and animal immuno-deficiency diseases. His patents also include pharmaceutical compositions containing polyprenyl compounds, which are effective as prophylactic agents against infectious diseases.
Career Highlights
Yamamoto is associated with Eisai Company, Limited, where he has been instrumental in advancing research and development in pharmaceutical sciences. His work has led to the creation of valuable therapeutic agents that have the potential to improve health outcomes.
Collaborations
Throughout his career, Hiroshi Yamamoto has collaborated with notable colleagues, including Masaichi Yamamoto and Seiichi Araki. These partnerships have fostered innovation and contributed to the success of their projects.
Conclusion
Hiroshi Yamamoto's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to impact the development of therapeutic agents for critical health issues.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.